Bipartisan congressional skepticism over any final U.S.-Iran nuclear agreement has solidified after the June 2026 memorandum of understanding failed to produce a comprehensive deal by its August deadline. Lawmakers from both parties have invoked the Iran Nuclear Agreement Review Act to demand formal review and a potential disapproval vote, citing concerns over sanctions relief, a proposed $300 billion reconstruction fund, and weak enforcement on Iran's nuclear program, ballistic missiles, and regional proxies. Renewed hostilities, conflicting U.S.-Iran statements on inspections, and violations of the interim ceasefire have further eroded support, leaving traders pricing in a low probability of passage even if talks resume before year-end.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गयाCongress approves Iran deal in 2026?
$13,118 वॉल्यूम
$13,118 वॉल्यूम
$13,118 वॉल्यूम
$13,118 वॉल्यूम
A qualifying bill or resolution must be a bill or joint resolution passed identically in both chambers, or a Senate resolution giving advice and consent to a treaty submitted by the President.
The resolution source for this market will be information from the United States Congress (https://congress.gov); however, a consensus of credible reporting will also be used.
बाज़ार खुला: Jun 16, 2026, 2:24 PM ET
रिज़ॉल्वर
0x65070BE91...A qualifying bill or resolution must be a bill or joint resolution passed identically in both chambers, or a Senate resolution giving advice and consent to a treaty submitted by the President.
The resolution source for this market will be information from the United States Congress (https://congress.gov); however, a consensus of credible reporting will also be used.
रिज़ॉल्वर
0x65070BE91...Bipartisan congressional skepticism over any final U.S.-Iran nuclear agreement has solidified after the June 2026 memorandum of understanding failed to produce a comprehensive deal by its August deadline. Lawmakers from both parties have invoked the Iran Nuclear Agreement Review Act to demand formal review and a potential disapproval vote, citing concerns over sanctions relief, a proposed $300 billion reconstruction fund, and weak enforcement on Iran's nuclear program, ballistic missiles, and regional proxies. Renewed hostilities, conflicting U.S.-Iran statements on inspections, and violations of the interim ceasefire have further eroded support, leaving traders pricing in a low probability of passage even if talks resume before year-end.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया



बाहरी लिंक से सावधान रहें।
बाहरी लिंक से सावधान रहें।
अक्सर पूछे जाने वाले प्रश्न